Lung Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Aug 30, 2018
- A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting.
Sorber Laure et al. Cancers 2018 Aug 10(9) - Brief report: c-MET overexpression as a poor predictor of MET amplifications or exon 14 mutations in lung sarcomatoid carcinomas.
Mignard Xavier et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Aug - Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry.
Bonaparte Eleonora et al. Diagnostic pathology 2018 Jan 13(1) 4 - Serum and blood based biomarkers for lung cancer screening: a systematic review.
Chu Gavin C W et al. BMC cancer 2018 18(1) 181 - Discoveries on the Genetics of ADHD in the 21st Century: New Findings and Their Implications.
Thapar Anita et al. The American journal of psychiatry 2018 Aug appiajp201818040383 - How scientists are trying to predict your future with your genes- But what are the limits? Genome-wide association studies, explained.
B Resnick et al, VOX, August 23, 2018 - Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective.
Jiang Wenxiao et al. Acta pharmaceutica Sinica. B 2018 Jul 8(4) 530-538 - The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer.
Laufer-Geva Smadar et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Aug - Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
Presley Carolyn J et al. JAMA 2018 Aug 320(5) 469-477 - Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision.
Bunn Paul A et al. JAMA 2018 Aug 320(5) 445-446
No hay comentarios:
Publicar un comentario